First Mercantile Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,440
Closed -$358K 858
2021
Q1
$358K Sell
1,440
-138
-9% -$32.9K 0.04% 251
2020
Q4
$363K Buy
1,578
+44
+3% +$10.1K 0.04% 251
2020
Q3
$360K Sell
1,534
-866
-36% -$215K 0.04% 230
2020
Q2
$566K Buy
2,400
+1,030
+75% +$235K 0.07% 155
2020
Q1
$278K Sell
1,370
-899
-40% -$196K 0.04% 257
2019
Q4
$547K Buy
2,269
+1,010
+80% +$223K 0.06% 208
2019
Q3
$244K Buy
+1,259
New +$242K 0.03% 422
2014
Q2
Sell
-21,238
Closed -$2.62M 1170
2014
Q1
$2.62M Buy
+21,238
New +$2.58M 0.19% 129

Other funds holding AMGN

First Mercantile Trust's AMGN Position: Q2 2021 in Review

First Mercantile Trust sold out of Amgen (AMGN) in Q2 2021, closing a stake of 1,440 shares — an estimated $358K sold.

First Mercantile Trust first reported a position in AMGN in Q1 2014 and held it in 8 quarters. The position peaked at $2.62M in Q1 2014. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • First Mercantile Trust reported no remaining Amgen position as of Q2 2021 after selling out during the quarter.
  • First Mercantile Trust sold 1,440 Amgen shares in Q2 2021, an estimated $358K.
  • First Mercantile Trust first reported a position in Amgen in Q1 2014 and held it in 8 quarters.
  • First Mercantile Trust's Amgen position peaked at $2.62M in Q1 2014.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on First Mercantile Trust's 13F filing for Q2 2021, filed 10 Aug 2021.